Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension

Rationale: Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives: To prospectively characterize the clinical presentation, histopathology,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Respir Crit Care Med
Asıl Yazarlar: Zamanian, Roham T., Hedlin, Haley, Greuenwald, Paul, Wilson, David M., Segal, Joshua I., Jorden, Michelle, Kudelko, Kristina, Liu, Juliana, Hsi, Andrew, Rupp, Allyson, Sweatt, Andrew J., Tuder, Rubin, Berry, Gerald J., Rabinovitch, Marlene, Doyle, Ramona L., de Jesus Perez, Vinicio, Kawut, Steven M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855067/
https://ncbi.nlm.nih.gov/pubmed/28934596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201705-0943OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller